Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
2 clinical trials · Condition
◉ Watch Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
| Record | Firm | Date |
|---|---|---|
| Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer (NCT03744793) | M.D. Anderson Cancer Center | 2019-04-11 |
| Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer (NCT03912818) | Stanford University | 2019-04-10 |
Track Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation automatically
Every clearance here is in the API, with alerts when new ones post.